STAG2 mutations were almost exclusively associated with an AML-MR diagnosis (256/271, 94%), with rare cases of NPM1 and bi-allelic CEBPA (8/271 (3%) and 5/271 (1.8%), respectively) (Table 2). The gene discussed is STAG2; the disease is acute myeloid leukemia.